RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Cellectar Biosciences Market capitalization 2024

Cellectar Biosciences Market capitalization

40.33 M USD

Cellectar Biosciences Dividend yield

Ticker

CLRB

ISIN

US15117F5008

WKN

A2NB71

In 2024, Cellectar Biosciences's market cap stood at 40.33 M USD, a 107.03% increase from the 19.48 M USD market cap in the previous year.

The Cellectar Biosciences Market capitalization history

YEARREVENUE (undefined USD)GROSS MARGIN (%)NET INCOME (undefined USD)
2029e349.81-124.05
2028e267.07-84.57
2027e192.33-50.18
2026e94.74-5.26
2025e45.16--18.98
2024e---53.72
2023---37.98
2022---28.6
2021---24.12
2020---15.09
2019---14.09
2018---15.48
2017---15.01
2016---6.18
2015---5.5
2014---8.05
2013---10.78
2012---9.34
2011---7.44
2010---4.56
20090.1--26.28
20080.13--22.96
2007---29.72

Cellectar Biosciences Aktienanalyse

What does Cellectar Biosciences do?

Cellectar Biosciences is a biotechnology company specializing in the development of innovative cancer therapies. It was founded in 2003 and is headquartered in Madison, Wisconsin, USA. The company's mission is to revolutionize cancer treatment by developing therapies with high efficacy. Cellectar Biosciences focuses on research and development in the areas of preclinical development, clinical trials, and product registration. It has expanded its business to include radiation therapy and imaging diagnostics. The company is divided into different divisions for effective work and specialization. It has partnerships with leading players in the biotechnology industry. Overall, Cellectar Biosciences has built an impressive portfolio of products and services to meet the needs of patients and healthcare providers and will continue to play a significant role in the biotechnology industry in the future. Cellectar Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Cellectar Biosciences's Market Capitalization

Cellectar Biosciences's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Cellectar Biosciences's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Cellectar Biosciences's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Cellectar Biosciences’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Cellectar Biosciences Stock

What is the current Cellectar Biosciences market capitalization?

The current market capitalization of Cellectar Biosciences is 40.33 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Cellectar Biosciences.

How has the market capitalization of Cellectar Biosciences developed in recent years?

The market capitalization of Cellectar Biosciences has increased/decreased by 107.03% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Cellectar Biosciences?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Cellectar Biosciences?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Cellectar Biosciences have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Cellectar Biosciences pay?

Over the past 12 months, Cellectar Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cellectar Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Cellectar Biosciences?

The current dividend yield of Cellectar Biosciences is .

When does Cellectar Biosciences pay dividends?

Cellectar Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cellectar Biosciences?

Cellectar Biosciences paid dividends every year for the past 0 years.

What is the dividend of Cellectar Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cellectar Biosciences located?

Cellectar Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cellectar Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cellectar Biosciences from 5/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.

When did Cellectar Biosciences pay the last dividend?

The last dividend was paid out on 5/20/2024.

What was the dividend of Cellectar Biosciences in the year 2023?

In the year 2023, Cellectar Biosciences distributed 0 USD as dividends.

In which currency does Cellectar Biosciences pay out the dividend?

The dividends of Cellectar Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cellectar Biosciences

Our stock analysis for Cellectar Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cellectar Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.